Toshiba America Medical Systems has introduced for its line of rotational angiography equipment 3D technology that simultaneously visualizes blood vessels and bone. The technology, dubbed three-dimensional fusion digital subtraction angiography
Toshiba America Medical Systems has introduced for its line of rotational angiography equipment 3D technology that simultaneously visualizes blood vessels and bone. The technology, dubbed three-dimensional fusion digital subtraction angiography (3D-FDSA), is designed to optimize neurovascular disease diagnosis and surgical planning on its Infinix i-series of vascular x-ray systems. The fusion capability combines separate reconstructions of blood vessels and bone structures in a single volumetric representation, illustrating intracranial vascular anomalies in the context of surrounding bone structures. It was developed in conjunction with neuroradiologists at Johns Hopkins University.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.